Dave Dunham is VP, Marketing, Growth & Business Development at the International Society for Pharmaceutical Engineering (ISPE), where he leads commercial strategy and business development initiatives supporting the global pharmaceutical industry. He brings more than 20 years of experience across pharmaceutical, medical technology, life sciences, and advanced technology markets, with leadership spanning business development, global marketing, product strategy, commercialization, and P&L management. Prior to ISPE, Dave held global roles at Medtronic, Onto Innovation, and Beckman Coulter, where he led strategy and commercialization for a global life sciences portfolio. Earlier in his career, he worked within Eli Lilly's neuroscience portfolio, providing additional perspective across the pharmaceutical value chain. He holds an MBA from Marylhurst University and a B.S. in Microbiology from Oregon State University.